Luciano Masini

Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study

Michèle Cavo, Patrizia Tosi, Elena Zamagni et al. · Journal of Clinical Oncology · 2007 · 373 citations · Full text

Medicine, Oncology, Cell Therapy +12

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

Michèle Cavo, Lucia Pantani, Maria Teresa Petrucci et al. · Blood · 2012 · 309 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

<i>Pneumocystis carinii</i> pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres

Livio Pagano, Luana Fianchi, Luca Mele et al. · British Journal of Haematology · 2002 · 146 citations · Full text

Medicine, Hematology, Infectious Diseases +16

Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.

Patrizia Tosi, Elena Zamagni, Claudia Cellini et al. · PubMed · 2002 · 111 citations

Medicine, Hematology, Pharmacology +16

A Phase III Study of Double Autotransplantation Incorporating Bortezomib-Thalidomide-Dexamethasone (VTD) or Thalidomide-Dexamethasone (TD) for Multiple Myeloma: Superior Clinical Outcomes with VTD Compared to TD.

Michèle Cavo, Paola Tacchetti, Francesca Patriarca et al. · Blood · 2009 · 48 citations

Medicine, Hematology, Pharmacotherapy +16